Skip to main content
PMC home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1998 Jul;79(1):F40–F43. doi: 10.1136/fn.79.1.f40

Outcome at 5-6 years of prematurely born children who received morphine as neonates

R MacGregor, D Evans, D Sugden, T Gaussen, M Levene
PMCID: PMC1720823  PMID: 9797623

Abstract

AIM—To assess outcome at 5-6 years in a cohort of very preterm infants (<34 weeks of gestation) who had been randomly allocated within a controlled clinical trial to receive morphine or non-morphine treatment in the neonatal period.
METHODS—Assessments were made on 87 children at 5-6 years who had been recruited in the neonatal period to two sequential controlled studies (1989-92). Infants requiring mechanical ventilation had been randomly allocated to receive either morphine (n=62) or other (n=33) solutions starting on the first day of life. Each child was seen by a single experienced observer and assessed at 5-6 years using the WPPSI-R, Movement ABC, and the Child Behaviour Checklist. The performance of children exposed to morphine was compared with that of those in the non-morphine group. Blood samples for thyroid stimulating hormone (TSH) measurement were obtained from children whose parents gave consent.
RESULTS—There was no significant difference in any of the three test scales between infants in the two groups, but there was a trend towards better performance in all three tests in the morphine group. Assessment of TSH values in a subgroup of the survivors showed no difference in thyroid function between the two groups.
CONCLUSION—Exposure to morphine in the neonatal period to facilitate mechanical ventilation does not seem to have any adverse effects on intelligence, motor function, or behaviour when these children are assessed at 5-6 years of age.



Full Text

The Full Text of this article is available as a PDF (112.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker D. P., Rutter N. Stress, severity of illness, and outcome in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed. 1996 Nov;75(3):F187–F190. doi: 10.1136/fn.75.3.f187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Hammer R. P., Jr, Ricalde A. A., Seatriz J. V. Effects of opiates on brain development. Neurotoxicology. 1989 Fall;10(3):475–483. [PubMed] [Google Scholar]
  3. Hartley R., Quinn M., Green M., Levene M. I. Morphine glucuronidation in premature neonates. Br J Clin Pharmacol. 1993 Mar;35(3):314–317. [PMC free article] [PubMed] [Google Scholar]
  4. Marcus J., Hans S. L., Jeremy R. J. A longitudinal study of offspring born to methadone-maintained women. III. Effects of multiple risk factors on development at 4, 8, and 12 months. Am J Drug Alcohol Abuse. 1984;10(2):195–207. doi: 10.3109/00952998409002780. [DOI] [PubMed] [Google Scholar]
  5. Niesink R. J., Vanderschuren L. J., van Ree J. M. Social play in juvenile rats after in utero exposure to morphine. Neurotoxicology. 1996 Fall-Winter;17(3-4):905–912. [PubMed] [Google Scholar]
  6. Quinn M. W., Otoo F., Rushforth J. A., Dean H. G., Puntis J. W., Wild J., Levene M. I. Effect of morphine and pancuronium on the stress response in ventilated preterm infants. Early Hum Dev. 1992 Oct;30(3):241–248. doi: 10.1016/0378-3782(92)90073-p. [DOI] [PubMed] [Google Scholar]
  7. Quinn M. W., Wild J., Dean H. G., Hartley R., Rushforth J. A., Puntis J. W., Levene M. I. Randomised double-blind controlled trial of effect of morphine on catecholamine concentrations in ventilated pre-term babies. Lancet. 1993 Aug 7;342(8867):324–327. doi: 10.1016/0140-6736(93)91472-x. [DOI] [PubMed] [Google Scholar]
  8. Ricalde A. A., Hammer R. P., Jr Perinatal opiate treatment delays growth of cortical dendrites. Neurosci Lett. 1990 Jul 31;115(2-3):137–143. doi: 10.1016/0304-3940(90)90444-e. [DOI] [PubMed] [Google Scholar]
  9. Seatriz J. V., Hammer R. P., Jr Effects of opiates on neuronal development in the rat cerebral cortex. Brain Res Bull. 1993;30(5-6):523–527. doi: 10.1016/0361-9230(93)90078-p. [DOI] [PubMed] [Google Scholar]
  10. Stiene-Martin A., Hauser K. F. Morphine suppresses DNA synthesis in cultured murine astrocytes from cortex, hippocampus and striatum. Neurosci Lett. 1993 Jul 9;157(1):1–3. doi: 10.1016/0304-3940(93)90628-x. [DOI] [PubMed] [Google Scholar]
  11. Tempel A. Visualization of mu opiate receptor downregulation following morphine treatment in neonatal rat brain. Brain Res Dev Brain Res. 1991 Dec 17;64(1-2):19–26. doi: 10.1016/0165-3806(91)90204-v. [DOI] [PubMed] [Google Scholar]
  12. Tempel A. Visualization of mu opiate receptor downregulation following morphine treatment in neonatal rat brain. Brain Res Dev Brain Res. 1991 Dec 17;64(1-2):19–26. doi: 10.1016/0165-3806(91)90204-v. [DOI] [PubMed] [Google Scholar]
  13. Wilson G. S., Desmond M. M., Verniaud W. M. Early development of infants of heroin-addicted mothers. Am J Dis Child. 1973 Oct;126(4):457–462. doi: 10.1001/archpedi.1973.02110190381004. [DOI] [PubMed] [Google Scholar]
  14. Wood C. M., Rushforth J. A., Hartley R., Dean H., Wild J., Levene M. I. Randomised double blind trial of morphine versus diamorphine for sedation of preterm neonates. Arch Dis Child Fetal Neonatal Ed. 1998 Jul;79(1):F34–F39. doi: 10.1136/fn.79.1.f34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Zagon I. S., McLaughlin P. J. Opioid antagonist-induced modulation of cerebral and hippocampal development: histological and morphometric studies. Brain Res. 1986 Aug;393(2):233–246. doi: 10.1016/0165-3806(86)90025-8. [DOI] [PubMed] [Google Scholar]
  16. van Baar A. Development of infants of drug dependent mothers. J Child Psychol Psychiatry. 1990 Sep;31(6):911–920. doi: 10.1111/j.1469-7610.1990.tb00833.x. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood. Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES